Publisher Correction: PAK4 inhibition improves PD-1 blockade immunotherapy,Nature Cancer

当前位置： X-MOL 学术 › Nat. Cancer › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Publisher Correction: PAK4 inhibition improves PD-1 blockade immunotherapy
Nature Cancer ( IF 23.5 ) Pub Date : 2020-01-22 , DOI: 10.1038/s43018-020-0025-7
Gabriel Abril-Rodriguez _{1,

2} , Davis Y Torrejon ₁ , Wei Liu _{3,

4} , Jesse M Zaretsky ₁ , Theodore S Nowicki ₅ , Jennifer Tsoi ₁ , Cristina Puig-Saus ₁ , Ignacio Baselga-Carretero ₁ , Egmidio Medina ₁ , Michael J Quist ₁ , Alejandro J Garcia ₁ , William Senapedis ₆ , Erkan Baloglu ₆ , Anusha Kalbasi _{7,

8,

9} , Gardenia Cheung-Lau ₁ , Beata Berent-Maoz ₁ , Begoña Comin-Anduix _{8,

9} , Siwen Hu-Lieskovan _{1,

9} , Cun-Yu Wang _{3,

4} , Catherine S Grasso ₁ , Antoni Ribas _{1,

2,

8,

9,

10}

Affiliation

Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA.
Laboratory of Molecular Signaling, Division of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, Los Angeles, CA, USA.
Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, Los Angeles, CA, USA.
Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of California, Los Angeles, Los Angeles, USA.
Karyopharm Therapeutics, Newton, MA, USA.
Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
Department of Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, CA, USA.
Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.
Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.